Affordable orphan drugs: a role for not-for-profit organizations-Reference-Cited by-同舟云学术

Affordable orphan drugs: a role for not-for-profit organizations

Published:2017-02-08 Issue:7 Volume:83 Page:1595-1601
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Davies Elin H.¹,Fulton Emma²,Brook Daniel²,Hughes Dyfrig A.¹

Affiliation:

1. Centre for Health Economics and Medicines Evaluation; Bangor University; Ardudwy, Holyhead Road Bangor LL57 2PZ UK

2. Hogan Lovells International LLP; London UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13240/fullpdf

Reference30 articles.

1. Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products OJ 2000 http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2000:018:0001:0005:en:PDF

2. Council Recommendation of 8 June 2009 on an action in the field of rare diseases (2009/C 151/02) OJ 2009 http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2009:151:0007:0010:EN:PDF

3. Effectiveness, safety and costs of orphan drugs: an evidence-based review;Onakpoya;BMJ Open,2015

4. Profitability and market value of orphan drug companies: a retrospective, propensity-matched case-control study;Hughes;PLoS One,2016

5. The quality of economic evaluations of ultra-orphan drugs in Europe - a systematic review;Schuller;Orphanet J Rare Dis,2015

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in orphan medicinal products approvals in the European Union between 2010–2022;Orphanet Journal of Rare Diseases;2024-02-27

2. Success of Drug Development for Cancer Diseases: Radicalness and Structural Holes;2024

3. Investigation of the diagnostic importance and accuracy of CT in the chest compared to the RT-PCR test for suspected COVID-19 patients in Jordan;F1000Research;2023-11-13

4. Pharmaceutical policy and innovation for rare diseases: A narrative review;F1000Research;2023-11-13

5. Assessment of the availability of repurposed orphan drugs in India;PLOS Global Public Health;2023-09-27